These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 23787494)
1. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects. Li W; Saji S; Sato F; Noda M; Toi M Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494 [TBL] [Abstract][Full Text] [Related]
2. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments. Lin H; Xu P; Huang M Future Med Chem; 2022 Jan; 14(1):35-51. PubMed ID: 34779649 [TBL] [Abstract][Full Text] [Related]
3. Seesaw of matrix metalloproteinases (MMPs). Kapoor C; Vaidya S; Wadhwan V; ; Kaur G; Pathak A J Cancer Res Ther; 2016; 12(1):28-35. PubMed ID: 27072206 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting. Abdel-Hamid NM; Abass SA Mol Biol Rep; 2021 Sep; 48(9):6525-6538. PubMed ID: 34379286 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview. Chaudhary AK; Pandya S; Ghosh K; Nadkarni A Mutat Res; 2013; 753(1):7-23. PubMed ID: 23370482 [TBL] [Abstract][Full Text] [Related]
7. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs). Rangasamy L; Geronimo BD; OrtÃn I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440 [TBL] [Abstract][Full Text] [Related]
8. Progress in the development of matrix metalloproteinase inhibitors. Tu G; Xu W; Huang H; Li S Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616 [TBL] [Abstract][Full Text] [Related]
9. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors. Tauro M; Laghezza A; Loiodice F; Agamennone M; Campestre C; Tortorella P Bioorg Med Chem; 2013 Nov; 21(21):6456-65. PubMed ID: 24071448 [TBL] [Abstract][Full Text] [Related]
10. New approaches to selectively target cancer-associated matrix metalloproteinase activity. Tauro M; McGuire J; Lynch CC Cancer Metastasis Rev; 2014 Dec; 33(4):1043-57. PubMed ID: 25325988 [TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes. Winer A; Adams S; Mignatti P Mol Cancer Ther; 2018 Jun; 17(6):1147-1155. PubMed ID: 29735645 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment. Yang JS; Lin CW; Su SC; Yang SF Expert Opin Drug Metab Toxicol; 2016; 12(2):191-200. PubMed ID: 26852787 [TBL] [Abstract][Full Text] [Related]
13. MMP inhibitors and cancer treatment trials, limitations and hopes for the future. Tlatli R; El Ayeb M Arch Inst Pasteur Tunis; 2013; 90(1-4):3-21. PubMed ID: 26012207 [TBL] [Abstract][Full Text] [Related]
14. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7. Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131 [TBL] [Abstract][Full Text] [Related]
15. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects. Levin M; Udi Y; Solomonov I; Sagi I Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874 [TBL] [Abstract][Full Text] [Related]
16. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment. Rashid ZA; Bardaweel SK Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569509 [TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics. Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG Cells; 2020 May; 9(5):. PubMed ID: 32466129 [TBL] [Abstract][Full Text] [Related]
18. Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer. Piperigkou Z; Manou D; Karamanou K; Theocharis AD Methods Mol Biol; 2018; 1731():325-348. PubMed ID: 29318564 [TBL] [Abstract][Full Text] [Related]
19. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. Gialeli C; Theocharis AD; Karamanos NK FEBS J; 2011 Jan; 278(1):16-27. PubMed ID: 21087457 [TBL] [Abstract][Full Text] [Related]